Home Newsfeeds JP Morgan Maintains Overweight on Oracle, Raises Price Target to $93

JP Morgan Maintains Overweight on Oracle, Raises Price Target to $93

JP Morgan analyst Mark Murphy maintains Oracle (NYSE:ORCL) with a Overweight and raises the price target from $87 to $93.

byBenzinga Newsdesk

March 10, 2023

1 minute read

JP Morgan analyst Mark Murphy maintains Oracle (NYSE:ORCL) with a Overweight and raises the price target from $87 to $93.

News

“American Bankers Association Calls For ‘Swift Passage’ Of Marijuana Banking Bill Ahead Of Senate Committee Hearing” – Marijuana Moment

By Happy Mohamed

May 9, 12:44 PM

https://www.marijuanamoment.net/american-bankers-association-calls-for-swift-passage-of-marijuana-banking-bill-ahead-of-senate-committee-hearing/ The American Bankers Association (ABA) is renewing its call for the

ACB

AstraZeneca Announced Enhertu Recommended for Approval in the EU by CHMP for Patients with HER2-low Metastatic Breast Cancer

By Charles Gross

December 19, 5:49 AM

AstraZeneca and Daiichi Sankyo's Enhertu is the first HER2-directed therapy to demonstrate a significant survival benefit vs. chemotherapy in this patient population.

AZN